(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 3.68%17.14B | 0.77%11.57B | 3.68%5.84B | 18.02%21.91B | 33.37%16.53B | 53.63%11.48B | 61.91%5.63B | 46.83%18.57B | 33.47%12.4B | 22.98%7.47B |
Operating income | 3.68%17.14B | 0.77%11.57B | 3.68%5.84B | 18.02%21.91B | 33.37%16.53B | 53.63%11.48B | 61.91%5.63B | 46.83%18.57B | 33.47%12.4B | 22.98%7.47B |
Cost of sales | ---- | -4.51%-7.8B | ---- | -1.71%-15.42B | ---- | -8.97%-7.47B | ---- | 9.42%-15.16B | ---- | -32.83%-6.85B |
Operating expenses | -7.04%-12.04B | -4.51%-7.8B | -1.99%-4B | -1.71%-15.42B | -2.19%-11.25B | -8.97%-7.47B | -19.63%-3.92B | 9.42%-15.16B | -33.72%-11B | -32.83%-6.85B |
Gross profit | -3.45%5.11B | -6.18%3.77B | 7.54%1.84B | 90.54%6.5B | 279.48%5.29B | 544.06%4.02B | 742.76%1.71B | 183.36%3.41B | 31.56%1.39B | -32.21%623.85M |
Selling expenses | -6.50%-47.37M | -11.19%-32.23M | -21.53%-15.93M | -34.44%-77M | -82.40%-44.48M | -82.98%-28.99M | -88.35%-13.1M | -13.78%-57.27M | -12.21%-24.38M | -3.26%-15.84M |
Administrative expenses | -1.68%-709.23M | -4.06%-498.77M | -3.94%-239.44M | -2.98%-975.96M | -8.59%-697.52M | -1.47%-479.33M | -54.00%-230.35M | -4.67%-947.75M | -10.54%-642.35M | -22.50%-472.36M |
Research and development expenses | 28.65%-11.92M | ---- | -31.57%-5.44M | ---- | -108.09%-16.71M | ---- | -142.30%-4.14M | ---- | 24.71%-8.03M | ---- |
Profit from asset sales | -76.29%95.25M | ---- | ---- | ---- | 2,568.39%401.81M | ---- | 15,488.54%249.31M | ---- | 539.93%15.06M | ---- |
Revaluation surplus | ---- | ---- | ---- | ---- | --3.3M | ---- | ---- | ---- | ---- | ---- |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | --3.3M | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | 98.92%-131.22K | 84.52%-2.2M | -1,696.28%-28.01K | -27,374.01%-1.21B | -188.61%-12.14M | -239.36%-14.23M | -118.98%-1.56K | -113.03%-4.4M | -12,821.66%-4.21M | 27.10%-4.19M |
-Other impairment is provision | 98.92%-131.22K | 84.52%-2.2M | -1,696.28%-28.01K | -27,374.01%-1.21B | -188.61%-12.14M | -239.36%-14.23M | -118.98%-1.56K | -113.03%-4.4M | -12,821.66%-4.21M | 27.10%-4.19M |
Special items of operating profit | -0.15%998.93M | -70.63%186.05M | -3.84%276.54M | 153.80%773.37M | 0.01%1B | 180.37%633.47M | -9.33%287.59M | -10.87%304.72M | -6.49%1B | -26.70%225.94M |
Operating profit | -8.37%5.34B | -17.10%3.42B | -7.11%1.82B | 85.13%5.01B | 246.95%5.83B | 1,055.29%4.13B | 457.51%1.96B | 157.91%2.7B | 14.36%1.68B | -56.51%357.39M |
Financing cost | -1.99%-881.05M | 8.82%-688.24M | 36.16%-261.35M | -46.26%-1.45B | -39.93%-863.85M | -63.12%-754.81M | -118.63%-409.41M | -20.24%-994M | 0.74%-617.34M | -8.86%-462.75M |
Share of profits of associates | ---- | 22.59%260.47M | ---- | 44.13%457.6M | ---- | 19.84%212.47M | ---- | 24.64%317.5M | ---- | 36.29%177.3M |
Share of profit from joint venture company | ---- | -2.32%348.58M | ---- | 0.69%730.29M | ---- | -1.88%356.84M | ---- | 1.54%725.26M | ---- | 4.41%363.7M |
Special items of earning before tax | 14.09%-10.41M | ---- | -165.61%-252.99K | ---- | 36.55%-12.12M | ---- | 5,284.50%385.57K | ---- | -14.92%-19.1M | ---- |
Earning before tax | -10.16%4.45B | -15.21%3.34B | 0.53%1.56B | 72.19%4.74B | 374.58%4.95B | 805.19%3.94B | 844.68%1.55B | 160.81%2.75B | 25.65%1.04B | -50.22%435.65M |
Tax | 15.46%-799.26M | 36.11%-545.7M | 36.84%-228.68M | -12.19%-1.08B | -489.94%-945.38M | -827.72%-854.17M | -526.58%-362.08M | -590.10%-964.76M | -3.71%-160.25M | 29.90%-92.07M |
After-tax profit from continuing operations | -8.92%3.65B | -9.43%2.8B | 11.93%1.33B | 104.57%3.66B | 353.65%4.01B | 799.15%3.09B | 1,017.75%1.19B | 138.31%1.79B | 30.67%883.52M | -53.81%343.58M |
Earning after tax | -8.92%3.65B | -9.43%2.8B | 11.93%1.33B | 104.57%3.66B | 353.65%4.01B | 799.15%3.09B | 1,017.75%1.19B | 138.31%1.79B | 30.67%883.52M | -53.81%343.58M |
Minority profit | -19.92%235.66M | -16.06%163.19M | 2.05%93.18M | -5.53%309.12M | 20.73%294.26M | 17.08%194.42M | 12.53%91.32M | 2.81%327.23M | 4.89%243.74M | 2.56%166.05M |
Profit attributable to shareholders | -8.05%3.42B | -8.99%2.63B | 12.76%1.24B | 129.23%3.35B | 480.49%3.71B | 1,530.67%2.89B | 4,272.57%1.1B | 129.30%1.46B | 44.17%639.78M | -69.50%177.53M |
Basic earnings per share | -8.05%0.7158 | -9.00%0.5522 | 12.76%0.259 | 129.08%0.7019 | 480.54%0.7785 | 1,526.81%0.6068 | 4,233.96%0.2297 | 129.27%0.3064 | 43.88%0.1341 | -69.48%0.0373 |
Diluted earnings per share | -7.94%0.7158 | -8.88%0.5522 | 12.76%0.259 | 129.38%0.7019 | 479.79%0.7775 | 1,529.03%0.606 | 4,233.96%0.2297 | 129.23%0.306 | 43.88%0.1341 | -69.56%0.0372 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data